250 participants enrolled in less than five months from first participant dosing, representing the fastest site activation and enrolment in…
Completed enrollment of 105 patients in Phase 3 registration study of TLX591-Px (Illuccix®) for prostate cancer imaging in Japan. The…
LONDON, July 16, 2026 /PRNewswire/ — New global research of 4,000 consumers finds loyalty programmes now rank among the biggest…
Architecture Proven in Allied Operations Now Available to Australian Commercial, Government, and Enterprise Organisations Eight years of architecture built for…
LONDON, July 16, 2026 /PRNewswire/ — New global research of 4,000 consumers finds loyalty programmes now rank among the biggest…
SYDNEY, July 16, 2026 /PRNewswire/ — FXTRADING.com has rebranded to FXT, introducing a new brand platform, "In Control. When Things…
SYDNEY, July 16, 2026 /PRNewswire/ — Vield, an Australian crypto-backed lending platform, has partnered with Integral, a leading currency technology provider,…
First-of-its-kind facility in Australia where radiopharmaceuticals are developed, manufactured and administered to patients under one roof. Patient care and research…
First patients dosed in OPTIMAL-e[1] Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent’s Hospital Sydney….
As financial markets increasingly embrace continuous trading, Pepperstone expands its Perpetual CFD suite, extending perpetual market mechanics within a regulated…
